{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:14:21Z","timestamp":1761743661402},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1007\/s12094-012-0833-z","type":"journal-article","created":{"date-parts":[[2012,7,3]],"date-time":"2012-07-03T02:19:46Z","timestamp":1341281986000},"page":"512-515","source":"Crossref","is-referenced-by-count":5,"title":["SEOM guidelines for endometrial cancer"],"prefix":"10.1007","volume":"14","author":[{"given":"Ana","family":"Oaknin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00edctor","family":"Rodr\u00edguez-Freixin\u00f3s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabela","family":"D\u00edaz de Corcuera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"del Campo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"833_CR1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","volume":"60","author":"A. Jemal","year":"2010","unstructured":"Jemal A, Siegel R, Xu J et al (2010) Cancer statistics, 2010. CA Cancer J Clin 60:277\u2013300","journal-title":"CA Cancer J Clin"},{"key":"833_CR2","first-page":"393","volume-title":"Blaustein's pathology of the female genital tract","author":"l. Ellenson","year":"2011","unstructured":"Ellenson lH, Ronnett BM, Soslow RA et al (2011) Endometrial carcinoma. In: Kurman RJ, Ellenson lH, Ronnett BM (eds) Blaustein's pathology of the female genital tract, 6th edn. Springer, Berlin, pp 393\u2013452","edition":"6th edn"},{"key":"833_CR3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","volume":"105","author":"S. Pecorelli","year":"2009","unstructured":"Pecorelli S (2009) Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 105:103\u2013104","journal-title":"Int J Gynaecol Obstet"},{"key":"833_CR4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0140-6736(08)61767-5","volume":"373","author":"P. Blake","year":"2009","unstructured":"ASTEC\/EN.5 Study Group. Blake P, Swart AM, Orton J et al (2009) Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis. lancet 373:137\u2013146","journal-title":"lancet"},{"key":"833_CR5","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","volume":"375","author":"R.A. Nout","year":"2010","unstructured":"Nout RA, Smit VT, Putter H et al (2010) Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, noninferiority, randomised trial. lancet 375:816\u2013823","journal-title":"lancet"},{"key":"833_CR6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(08)61766-3","volume":"373","author":"H. Kitchener","year":"2009","unstructured":"Kitchener H, Swart AM, Qian Q et al (2009) Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. lancet 373:125\u2013136","journal-title":"lancet"},{"key":"833_CR7","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1093\/jnci\/djn397","volume":"100","author":"P. Benedetti Panici","year":"2008","unstructured":"Benedetti Panici P, Basile S, Maneschi F et al (2008) Systemic pelvic lymphadenectomy vs no lymphadenectomy in early stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 100:1707\u20131716","journal-title":"J Natl Cancer Inst"},{"key":"833_CR8","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","volume":"355","author":"C. Creutzberg","year":"2000","unstructured":"Creutzberg C, van Putten Wl, Koper P et al (2000) Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomized trial. Lancet 355:1404\u20131411","journal-title":"Lancet"},{"key":"833_CR9","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","volume":"92","author":"H.M. Keys","year":"2004","unstructured":"Keys HM, Roberts JA, Brunetto Vl et al (2004) A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecolgic Oncology Group study. Gynecol Oncol 92:744\u2013751","journal-title":"Gynecol Oncol"},{"key":"833_CR10","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/sj.bjc.6603279","volume":"95","author":"R. Maggi","year":"2006","unstructured":"Maggi R, Lissoni A, Spina A et al (2006) Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial. Br J Cancer 95:266\u2013271","journal-title":"Br J Cancer"},{"key":"833_CR11","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ygyno.2007.09.029","volume":"108","author":"N. Susumu","year":"2008","unstructured":"Susumu N, Sagae S, Udagawa y et al (2008) Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study. Gynecol Oncol 108:226\u2013233","journal-title":"Gynecol Oncol"},{"key":"833_CR12","first-page":"2422","volume":"46","author":"T. Hogberg","year":"2010","unstructured":"Hogberg T, Signorelli M, de Oliveira CF et al (2010) Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer. Results from two randomized studies. Eur J Cancer 46:2422\u20132431","journal-title":"Results from two randomized studies. Eur J Cancer"},{"key":"833_CR13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ygyno.2006.02.007","volume":"103","author":"K. Greven","year":"2006","unstructured":"Greven K, Winter K, Underhill K et al (2006) Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin\/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer. Gynecol Oncol 103:155\u2013159","journal-title":"Gynecol Oncol"},{"key":"833_CR14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1200\/JCO.2004.00.7617","volume":"24","author":"M.E. Randall","year":"2006","unstructured":"Randall ME, Filiaci Vl, Muss H et al (2006) Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group study. J Clin Oncol 24:36\u201344","journal-title":"J Clin Oncol"},{"key":"833_CR15","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1200\/JCO.2004.02.088","volume":"22","author":"J.T. Thigpen","year":"2004","unstructured":"Thigpen JT, Brady MF, Homesley HD et al (2004) Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a Gynecologic Oncology Group study. J Clin Oncol 22:3902\u20133908","journal-title":"J Clin Oncol"},{"key":"833_CR16","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1200\/JCO.2004.07.184","volume":"22","author":"G.F. Fleming","year":"2004","unstructured":"Fleming GF, Brunnetto Vl, Cella D et al (2004) Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgastrim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol 22:2159\u20132166","journal-title":"J Clin Oncol"},{"key":"833_CR17","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1200\/JCO.1999.17.6.1736","volume":"17","author":"J.T. Thigpen","year":"1999","unstructured":"Thigpen JT, Brady MF, Alvarez RD et al (1999) Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology Group. J Clin Oncol 17:1736\u20131744","journal-title":"J Clin Oncol"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-012-0833-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-012-0833-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-012-0833-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T23:51:30Z","timestamp":1559433090000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-012-0833-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":17,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["833"],"URL":"https:\/\/doi.org\/10.1007\/s12094-012-0833-z","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}